Related Experiment Videos
[Cancer prevention]
Hideyuki Akaza1, Takashi Tsuruo, Nagahiro Saijo
1Dept. of Urology, Institute of Clinical Medicine, University of Tsukuba.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|October 18, 2005
Summary
Cancer prevention in Japan is evolving, with a focus on screening for common cancers like stomach and breast. Challenges remain in widespread implementation and developing safe, effective pharmaceutical prevention strategies.
Area of Science:
- Oncology
- Public Health
- Cancer Prevention Research
Context:
- The 12th Oncology Forum highlighted Japan's progress and future strategies in cancer prevention.
- The National Cancer Center is focusing on screening for six common cancers: stomach, lung, liver, colon, breast, and uterus.
- Current screening programs show a high cumulative detection rate, potentially due to subject selection.
Purpose:
- To discuss the current state and future directions of cancer prevention strategies in Japan.
- To identify challenges and opportunities in implementing widespread cancer screening and chemoprevention.
- To explore the difficulties in developing pharmaceutical cancer prevention treatments.
Summary:
- A dedicated research center focuses on screening for prevalent cancers, achieving a notable detection rate.
- Research is ongoing for prostate cancer screening and chemoprevention, with accessibility as a key issue.
- Identifying high-risk individuals for breast cancer (obesity, family history) and evaluating dietary interventions for colorectal cancer are areas of study.
- Developing pharmaceutical prevention is hindered by the requirement for high safety profiles and lengthy study durations.
- Existing infrastructure is insufficient for broad implementation of general screening and prevention programs.
Impact:
- Highlights the need for new approaches and government-level infrastructure development for effective cancer prevention.
- Identifies key challenges in making cancer prevention strategies widely accessible and implementable.
- Emphasizes the ongoing evolution of cancer prevention, requiring further research and strategic planning.